1. Home
  2. KURA vs KRO Comparison

KURA vs KRO Comparison

Compare KURA & KRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KURA
  • KRO
  • Stock Information
  • Founded
  • KURA 2014
  • KRO 1916
  • Country
  • KURA United States
  • KRO United States
  • Employees
  • KURA N/A
  • KRO N/A
  • Industry
  • KURA Biotechnology: Biological Products (No Diagnostic Substances)
  • KRO Major Chemicals
  • Sector
  • KURA Health Care
  • KRO Industrials
  • Exchange
  • KURA Nasdaq
  • KRO Nasdaq
  • Market Cap
  • KURA 1.3B
  • KRO 1.3B
  • IPO Year
  • KURA N/A
  • KRO N/A
  • Fundamental
  • Price
  • KURA $15.92
  • KRO $11.37
  • Analyst Decision
  • KURA Strong Buy
  • KRO Hold
  • Analyst Count
  • KURA 7
  • KRO 3
  • Target Price
  • KURA $29.83
  • KRO $12.00
  • AVG Volume (30 Days)
  • KURA 821.5K
  • KRO 157.1K
  • Earning Date
  • KURA 11-07-2024
  • KRO 11-06-2024
  • Dividend Yield
  • KURA N/A
  • KRO 1.76%
  • EPS Growth
  • KURA N/A
  • KRO N/A
  • EPS
  • KURA N/A
  • KRO 0.82
  • Revenue
  • KURA N/A
  • KRO $1,864,100,000.00
  • Revenue This Year
  • KURA N/A
  • KRO $27.63
  • Revenue Next Year
  • KURA N/A
  • KRO $10.25
  • P/E Ratio
  • KURA N/A
  • KRO $13.89
  • Revenue Growth
  • KURA N/A
  • KRO 15.87
  • 52 Week Low
  • KURA $9.06
  • KRO $8.23
  • 52 Week High
  • KURA $24.17
  • KRO $14.50
  • Technical
  • Relative Strength Index (RSI)
  • KURA 34.68
  • KRO 42.70
  • Support Level
  • KURA $16.55
  • KRO $11.20
  • Resistance Level
  • KURA $19.73
  • KRO $12.98
  • Average True Range (ATR)
  • KURA 0.98
  • KRO 0.43
  • MACD
  • KURA -0.05
  • KRO -0.07
  • Stochastic Oscillator
  • KURA 8.86
  • KRO 11.54

About KURA Kura Oncology Inc.

Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operation of the group is carried through the United States.

About KRO Kronos Worldwide Inc

Kronos Worldwide Inc manufactures and sells titanium dioxide pigments. Titanium dioxide is a white inorganic pigment used in a variety of products. The majority of Kronos' sales come from titanium dioxide used for coatings on automobiles, aircraft, machines, appliances, traffic paint, and in both commercial and residential interiors and exteriors. The second-largest product category is titanium dioxide used for plastics such as packaging materials and food packaging, houseware, appliances, toys, and computer cases. The majority of revenue comes from the United States.

Share on Social Networks: